[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100607248":3},{"organization":4,"outcomesModule":7,"designInfo":18,"detailedDescription":29,"studyPopulation":11,"armGroups":30,"interventions":42,"overallOfficials":52,"centralContacts":57,"locations":63,"responsibleParty":79,"collaborators":82,"id":84,"slug":85,"hasResults":86,"nctId":87,"briefTitle":88,"officialTitle":89,"acronym":11,"eligibilityCriteria":90,"healthyVolunteers":86,"sex":91,"minAge":92,"maxAge":93,"enrollmentInfo":94,"targetDuration":11,"studyType":97,"phases":98,"briefSummary":100,"conditions":101,"keywords":11,"overallStatus":103,"whyStopped":11,"lastUpdateSubmitDate":104,"lastUpdatePostDateStruct":105,"startDateStruct":108,"completionDateStruct":110,"leadSponsor":112,"locationsCount":113},{"fullName":5,"class":6},"Tianjin Medical University Eye Hospital","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":11},[9],{"measure":10,"description":11,"timeFrame":12},"Axial length",null,"From enrollment to the end of treatment up to 7 months",[14,16],{"measure":15,"description":11,"timeFrame":12},"Spherical equivalent",{"measure":17,"description":11,"timeFrame":12},"Choroidal thickness",{"allocation":19,"interventionModel":20,"interventionModelDescription":11,"primaryPurpose":21,"observationalModel":11,"timePerspective":11,"maskingInfo":22},"RANDOMIZED","PARALLEL","TREATMENT",{"masking":23,"maskingDescription":11,"whoMasked":24},"QUADRUPLE",[25,26,27,28],"PARTICIPANT","CARE_PROVIDER","INVESTIGATOR","OUTCOMES_ASSESSOR","The experiment will be divided into two phases. In the first phase, the subjects will be randomly grouped using laser equipment and LED equipment, and each group will be exposed to the red light twice a day for one month. The second stage involves self-comparison of the laser equipment, with the usage frequencies being once a day and three times a day.\n\nTo explore the effectiveness and safety of repeated exposure to repeated low-intensity red light in different devices and frequencies, as well as its impact on the axial length, spherical equivalent refraction and choroidal thickness of myopia progression.",[31,37],{"label":32,"type":33,"description":34,"interventionNames":35},"The Laser Group","EXPERIMENTAL","Use Eyerising (RS-200-2A), 1 time,2 times or 3 times a day",[36],"Device: Eyerising RS-200-2A",{"label":38,"type":33,"description":39,"interventionNames":40},"The LED Group","Use Airdoc (Sky-n1201), 2 times a day",[41],"Device: Airdoc Sky-n1201",[43,48],{"type":44,"name":45,"description":46,"armGroupLabels":47,"otherNames":11},"DEVICE","Eyerising RS-200-2A","Eyerising RS-200-2A,1 time,2 times, 3 times a day",[32],{"type":44,"name":49,"description":50,"armGroupLabels":51,"otherNames":11},"Airdoc Sky-n1201","Eyerising RS-200-2A,2 times a day",[38],[53],{"name":54,"affiliation":55,"role":56},"Ruihua Wei","Tianjin Medical University Eye Hospital, Tianjin, Tianjin 120120 Recruiting","PRINCIPAL_INVESTIGATOR",[58],{"name":59,"role":60,"phone":61,"phoneExt":11,"email":62},"Guihua Liu","CONTACT","+8686428756","liuguihua1992@163.com",[64],{"facility":5,"status":11,"city":65,"state":66,"zip":67,"country":68,"countryCode":69,"cosmosGeoPoint":70,"geoPoint":75,"contacts":76},"Tianjin","Tianjin Municipality","120120","China","CN",{"type":71,"coordinates":72},"Point",[73,74],117.17667,39.14222,{"lat":74,"lon":73},[77],{"name":59,"role":60,"phone":78,"phoneExt":11,"email":62},"8686428756",{"type":80,"investigatorFullName":54,"investigatorTitle":81,"investigatorAffiliation":5,"oldNameTitle":11,"oldOrganization":11},"SPONSOR_INVESTIGATOR","Professor",[83],{"name":5,"class":6},"100607248","therapeutic-efficacy-of-different-repeated-low-intensity-red-light-devices-and-different-usage-frequencies-100607248",false,"NCT07186088","Therapeutic Efficacy of Different Repeated Low-Intensity Red Light Devices and Different Usage Frequencies","Study on the Therapeutic Efficacy of Different Repeated Low-Intensity Red Light Devices and Different Usage Frequencies for Adult Myopia Treatment","Inclusion Criteria:\n\n* 18-35 years old, gender not limited; Obtained informed consent.\n\nExclusion Criteria:\n\n* Obvious strabismus and amblyopia\n* With congenital eye disease, such as congenital cataract, congenital retinal disease\n* Secondary myopia (such as premature retinopathy or other eye diseases in infants and children caused secondary myopia), or myopia combined with systemic syndrome (such as Marfan syndrome)\n* Had internal eye surgery (such as cataract extraction, intraocular lens implantation, anti-glaucoma surgery, etc.)\n* Refractive medium opacity (such as corneal disease, crystal opacity, etc.)\n* Bnormal intraocular pressure and clinical significance (IOP \\\u003C10 mmHg or IOP\\>21mmHg or binocular IOP difference ≥5mmHg)\n* Fundus chorioretinopathy (except for high myopia fundus degenerative changes) or other intraocular diseases\n* Optic nerve damage or congenital optic nerve dysfunction\n* Can not be regularly checked\n* The adjustment range is less than 8D or obvious near difficulties\n* Other reasons researchers think it is not suitable for inclusion in researchers","ALL","18 Years","35 Years",{"count":95,"type":96},30,"ESTIMATED","INTERVENTIONAL",[99],"NA","To explore the effectiveness and safety of repeated exposure to repeated low-intensity red light",[102],"Myopia","NOT_YET_RECRUITING","2025-09-15",{"date":106,"type":107},"2025-09-22","ACTUAL",{"date":109,"type":96},"2025-09-20",{"date":111,"type":96},"2026-06-20",{"name":54,"class":6},1]